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Objectives: Epigenetic phenomena are changes in gene expression not involving
the DNA sequence. DNA methylation is a major occurrence underlying epigenetic
changes in human cells. Although aberrant DNA methylation is well documented in
malignant lesions, limited information has been shown on the involvement of DNA
methylation in oral lichen planus and oral lichenoid lesions (OLP). The present study
aimed to investigate DNA methylation of E-cadherin and p16 in OLP, and compare
the findings with those in non-inflamed gingiva (Non), radicular cyst (RC), and oral
squamous cell carcinoma (SCC).
Materials and methods: Paraffin-embedded surgical biopsy specimens were sliced,
DNA was extracted, bisulfite treatment was applied, and methylation-specific poly-
merase chain reaction was performed. Immunohistochemistry was performed to
observe the relative expression patterns of these genes.
Results: E-cadherin was hypermethylated in OLP (p < 0.01), SCC (p < 0.01), and RC
(p < 0.05), when compared with Non; DNA hypermethylation was confirmed in
OLP and SCC when compared to Non and RC. Hypermethylation of p16ink4a was
observed only in SCC (p < 0.01).
Conclusion: DNA methylation levels of E-cadherin and p16ink4a were significantly
higher in OLP than in normal tissues, and may be associated with the pathogenesis
and progression of the disease.
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1 | INTRODUCTION
Oral lichen planus and oral lichenoid lesions (OLP) is a chronic
inflammatory disease that involves the oral mucosa (Al-Hashimi
et al., 2007). The precise etiology of OLP is unknown; genetic back-
ground, systemic associations, and environmental factors such as den-
tal metals, drugs or viral infections have been involved in OLP
(Alrashdan et al., 2016). Environmental factors are known to
cause epigenetic modifications, wherein only the pattern of gene
expression is altered but not the DNA sequence. Alterations in DNA
methylation form a crucial part of epigenetic modification (García &
García-García, 2012; Jithesh et al., 2013; Qiu et al., 2004). Oral
cancerous and precancerous lesions have shown aberrant epigenetic
modifications, including hypermethylation of tumor-related genes
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(Castilho et al., 2017; Hema et al., 2017; Lingen et al., 2011) such
as E-cadherin and p16ink4a (Castilho et al., 2017; Hema et al., 2017;
Lingen et al., 2011). E-cadherin is a 120 kDa glycoprotein in a part
of the adhesive junctions and functions as a tumor suppressor gene.
The hypermethylation of E-cadherin followed by the downregulated
expression of this gene leads to malignant transformation and
tumor progression (Burassakarn et al., 2017). The p16ink4a protein
functions as a negative regulator of cell cycle progression via inhibi-
tion of both cyclin-dependent kinase (CDK) 4 and 6 followed by Rb
cyclin-dependent phosphorylation (Montebugnoli et al., 2011). The
reduction of p16ink4a promotes cell growth and often contributes to
malignant transformation (Okuma et al., 2017). In OLP, aberrant
immunohistochemical staining for both E-cadherin and p16ink4a have
been reported (Ebrahimi et al., 2008; Lee et al., 2016; Montebugnoli
et al., 2011; Sridevi et al., 2015); however, the mechanisms involved
in these phenomena remain unknown. Herein, we hypothesized that
E-cadherin and p16ink4a hypermethylations may cause the aberrant
expression of these proteins, based on which, we examined DNA
methylations in the promoter regions of E-cadherin and p16ink4a in
OLP, and compared them with those in non-inflamed healthy gingiva
(Non), radicular cyst (RC), and oral squamous cell carcinoma (SCC).
2 | MATERIALS AND METHODS
2.1 | Samples
Biopsy samples embedded in paraffin and surgical materials of OLP
(n = 26), RC (n = 31), SCC (n = 25), and Non (n = 25) were used in this
study. The OLP samples were collected by the following histopathologi-
cal diagnostic criteria; hyperkeratosis, parakeratosis, basal cell hydropic
change, Civatte bodies, a band-like lymphocytic infiltrate in the lamina
propria, and excluding the presence of dysplasia or malignant tumor
(Al-Hashimi et al., 2007; Cheng et al., 2016). The study was approved by
the ethics committee of Institute of Personalized Medical Science,
Health Sciences University of Hokkaido (No. 2012–005). Paraffin sec-
tions were prepared with a microtome and used for methylation-specific
PCR (MSP) and immunohistochemistry.
2.2 | Quantitative methylation specific PCR assay
DNA methylation levels in CpG islands were analyzed using the Quanti-
tative methylation-specific PCR (qMSP) assay. Genomic DNA was
extracted from paraffin sections using the Epitect Plus FFPE Lysis kit
(Qiagen, Venlo, Netherland). The DNA samples were treated with
sodium bisulfite using the EpiTect Plus Bisulfite Kits (Qiagen). DNA
methylation of E-cadherin and p16ink4a genes were analyzed by SYBR
green-based qMSP. The methylated and unmethylated primers were
designed as described in a previous study (Table 1) (Herman et al., 1996).
PCR was performed in a total volume of 25 μl, with 1.0 μl of bisulfite-
treated DNA template mixed with 12.5 μl of KAPA SYBR FAST qPCR
Kit (Nippon Genetics, Tokyo, Japan) and a pair of primers at a final con-
centration of 400 nM. The PCR conditions included initial incubation at
50C for 2 min, denaturation at 95C for 10 min, 40 cycles of denatur-
ation at 95C for 15 s, and annealing at 58C for 1 min. After PCR ampli-
fication, a dissociation curve was generated to confirm the size of the
PCR product. The percentages of E-cadherin and p16ink4a methylation in
a sample were estimated using the following formula (Lu et al., 2007):






U are the copy numbers of methylated and unmethylated E-cadherin/
p16ink4a, respectively, and ΔCq = CqU−CqM.
2.3 | Immunohistochemistry
Immunohistochemical localizations of E-cadherin and p16ink4a were
observed in the tissue sections. The slides were deparaffinized in xylene
(3 changes for 3 min each) and rehydrated in a series of graded alcohol
(100, 90, 80, and 70% each for 3 min). Endogenous peroxidase activity
on the slide was blocked with 3% H2O2 in methanol for 10 min. Mouse
Anti-Human E-cadherin monoclonal antibody (DAKO, Tokyo, Japan) and
rabbit anti-clone EPR1473 p16 monoclonal antibody (DAKO) were used
as primary antibodies. EnVision + system-HRP-labeled polymer anti-
mouse and anti-rabbit were used as secondary antibodies (DAKO).
Reaction products were visualized with diaminobenzidine chromogen
concentrate (Dako), and finally counterstained with hematoxylin. Immu-
nostaining was graded as − (<10% positively stained cells), ± (10%–25%
positively stained cells; weak expression), + (25%–50% positively stained
cells; mild to moderate expression), and ++ (50%–100% positive cells;
moderate to strong expression).
2.4 | Statistical analysis
Statistical analysis was performed on a database using the IBM SPSS
Statistics 23 (IBM, Armonk, NY). Results were compared using
the Kruskal–Wallis test. Data are presented as means ± standard
TABLE 1 Primer sequences (50 to 30)
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Lingen et al. (2011)
Lingen et al. (2011)
Abbreviations: M, methylation primer; U, unmethylation primer.
206 CHUJO ET AL.
F IGURE 2 The percentage of DNA methylation of p16ink4a as
measured by qMSP. DNA methylation levels of p16ink4a were
significantly higher in OLP than in Non and RC (p < 0 .01), and
significantly lower in OLP than in SCC (p < 0.01). **p < 0.01
F IGURE 3 Immunohistochemical staining for E-cadherin (magnification, ×200). Immunohistochemical staining for E-cadherin was mainly
localized at the intercellular contact areas in the basal to spinous layers in OLP. No positive staining was observed in the keratinized layers. The
positive reactions were stronger and more extensive in Non and RC when compared to OLP. The staining grades were ++ in Control and RC, and
+ in OLP and SCC
F IGURE 1 The percentage of DNA methylation of E-cadherin as
measured by qMSP. DNA methylation levels of E-cadherin were
significantly higher in OLP than in Non (p < 0 .01) and RC (p < 0.05),
whereas no significant difference was found between OLP and SCC.
*p < 0.05, **p < 0.01
CHUJO ET AL. 207
deviation (SD), and significance levels were set at *p < 0.05 and **p <
0 .01 when compared with the controls.
3 | RESULTS
DNA methylation levels of E-cadherin were significantly higher in
OLP than in Non and RC (p < 0.05), whereas no significant difference
was found between OLP and SCC (Figure 1). Similarly, significantly
higher levels of p16ink4a DNA methylation were observed in OLP
when compared with both Non and RC (p < 0.05); on the other hand,
the methylation level in OLP was significantly lower than that in SCC
(p < 0.05, Figure 2).
Immunohistochemical staining for E-cadherin was mainly local-
ized at the intercellular contact areas in the basal to spinous layers
in OLP. No positive staining was observed in the keratinized layers.
The positive reactions were stronger and wider in Non and RC than
in OLP, and the grades were as follows: ++ in Control and RC,
and + in OLP and SCC (Figure 3). Immunohistochemical staining for
p16ink4a was observed in the nuclei of the cells in the basal and spi-
nous layers in OLP. The positive reactions were wider in Non than
in OLP, and were graded as ++ in RC and + in OLP, Non, and SCC
(Figure 4).
4 | DISCUSSION
In the present study, we examined the DNA hypermethylation of
E-cadherin and p16ink4a in OLP, and compared the results with those
in non-inflamed epithelial tissues (Non), non-specific inflammatory
epithelial tissues obtained from RC, and oral SCC. The methylation
levels of E-cadherin in OLP were higher than that in Non and RC, and
similar to that in SCC. The methylation levels of p16ink4a in OLP were
significantly higher than that in Non and RC, but lower than that in
SCC. Thus, hypermethylation of both E-cadherin and p16ink4a may be
observed in OLP.
F IGURE 4 Immunohistochemical staining for p16ink4a (magnification, ×200). In OLP, immunohistochemical staining for p16ink4a was observed
in the nuclei of cells in the basal and spinous layers. The positive reactions were more widespread in Non than in OLP. The grades of positive
staining were ++ in RC and + in OLP, Non, and SCC
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Hypermethylations of E-cadherin and p16ink4a have been
reported in malignant tumors, including oral SCC (Viswanathan
et al., 2003). The hypermethylation of E-cadherin followed by a down-
regulation in its expression levels leads to malignant transformation
and tumor progression (Pannone et al., 2014; Schmalhofer et al.,
2009). The reduction of p16ink4a promotes cell growth and often
contributes to malignant transformation (Kato et al., 2006). Although
E-cadherin hypermethylation in OLP not been demonstrated so far,
aberrant immunohistochemical staining of E-cadherin was reported
(Du & Li, 2015). Loss of membrane expression and decreased expres-
sion levels of E-cadherin were observed in OLP (Sridevi et al.,
2015). Consistent with the previous reports (Sridevi et al., 2015),
the results of the current study showed a significantly lower
expression of E-cadherin in OLP when compared to that in Non or
RC. However, these reports did not state the mechanism involved in
the aberrant immunohistochemical expression. Hypermethylation
results in the downregulated expression of the gene. We believe that
hypermethylation may cause the aberrant expression of E-cadherin,
which has been linked to malignancy in OLP (Du & Li, 2015). Thus, the
involvement of aberrant E-cadherin expression in the pathogenesis of
OLP should not be ruled out. Metal allergy is one of the environmen-
tal factors associated with the etiology of oral lichen planus/oral
lichenoid lesions (Suter & Warnakulasuriya, 2016), and may be associ-
ated with that of OLP, although the precise etiology of OLP remains
unknown. A previous study showed E-cadherin hypermethylation
induced by nickel in bronchial epithelial cells (Wu et al., 2012).
Thus, other metals similar to nickel may directly cause OLP via
hypermethylation of E-cadherin. Nonetheless, additional researches
are needed to clarify this speculation.
Frequent methylation of p16ink4a in OLP has been reported
recently (Dang et al., 2013) wherein p16ink4a levels in OLP patients
were found to be higher than that in heathy subjects, and lower than
that in SCC. These findings are similar to those observed in the pre-
sent study. Aberrant immunohistochemical staining for p16ink4a has
also been demonstrated previously (Nasser et al., 2011) with
increased staining in OLP when compared to normal controls
(Poomsawat et al., 2011). A previous paper suggested that the posi-
tive staining for p16ink4a in OLP is associated with eactive inflamma-
tory processes rather than the progression risk to malignant tumor
(Montebugnoli et al., 2011). The immunohistochemical findings of the
current study showed increased positive staining in RC than in OLP
and Non. Although our results were not in accordance with those
reported previously, the increased positive reactions for p16ink4a
observed in RC may support the suggestion that p16ink4a staining is
related to reactive inflammatory processes. However, the mechanism
by which p16ink4a hypermethylation is involved in its aberrant expres-
sion needs to be investigated in future.
In conclusion, the present study demonstrated that the
methylation levels of E-cadherin and p16ink4a in OLP were signifi-
cantly higher than that in normal tissues suggesting that the
hypermethylation of these genes may be related to the pathogenesis
and progression of OLP. In addition, epigenetic modifications due to
environmental factors may also be involved in the pathogenesis of
OLP. However, further investigations are needed to prove this
hypothesis.
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